Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7580405

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Consolidated statement of income
Statement of income
Net sales
155,808,000 JPY
354,410,000 JPY
Cost of sales
70,702,000 JPY
315,174,000 JPY
Operating expenses
Selling, general and administrative expenses
1,750,655,000 JPY
1,491,591,000 JPY
Depreciation
868,000 JPY
3,448,000 JPY
Operating expenses
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
62,425,000 JPY
74,400,000 JPY
Ordinary profit (loss)
-1,678,084,000 JPY
-1,569,648,000 JPY
Operating expenses
Research and development expenses
1,387,674,000 JPY
1,146,584,000 JPY
Operating profit (loss)
-1,665,548,000 JPY
-1,452,355,000 JPY
Net sales
Gross profit (loss)
85,106,000 JPY
39,235,000 JPY
General and administrative expenses
Salaries
Selling, general and administrative expenses
Non-operating income
Interest income
1,762,000 JPY
1,085,000 JPY
Other
665,000 JPY
2,625,000 JPY
Non-operating income
20,111,000 JPY
47,134,000 JPY
Cost of sales
Non-operating expenses
Other
JPY
409,000 JPY
Non-operating expenses
32,647,000 JPY
164,426,000 JPY
Share issuance costs
JPY
11,772,000 JPY
Extraordinary losses
202,445,000 JPY
2,549,000 JPY
Impairment losses
194,829,000 JPY
JPY
Other
415,000 JPY
JPY
Profit (loss) before income taxes
-1,880,529,000 JPY
-1,572,198,000 JPY
Gross profit
Income taxes - current
3,670,000 JPY
4,354,000 JPY
Income taxes - deferred
118,000 JPY
590,000 JPY
Extraordinary losses
Income taxes
3,788,000 JPY
4,944,000 JPY
Profit (loss)
-1,884,318,000 JPY
-1,884,318,000 JPY
-1,884,318,000 JPY
-1,884,318,000 JPY
-1,577,142,000 JPY
-1,577,142,000 JPY
-1,577,142,000 JPY
-1,577,142,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.